Q2 2023 Holdings
Filed 2023-08-14 | 22 holdings | $609.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Iveric BIO Inc(OPHTEUR) | COMM | 46583P102 | $96.3M | 2,448,829 | 15.8% |
| Geron Corp(GERN) | COMM | 374163103 | $75.7M | 23,589,779 | 12.4% |
| Cogent Biosciences Inc(COGT) | COMM | 19240Q201 | $66.7M | 5,631,042 | 10.9% |
| Vectivbio Holding AG | COMM | H9060V101 | $52.9M | 3,113,600 | 8.7% |
| Aerovate Therapeutics Inc | COMM | 008064107 | $37.8M | 2,201,274 | 6.2% |
| Icosavac, Inc | COMM | 45114M109 | $36.8M | 3,703,704 | 6.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COMM | 558868105 | $34.6M | 149,917 | 5.7% |
| Tyra Biosciences Inc(TYRA) | COMM | 90240B106 | $33.9M | 1,989,103 | 5.6% |
| Kalvista Pharmaceuticals, Inc(KALV) | COMM | 483497103 | $30.6M | 3,395,495 | 5.0% |
| Ventyx Biosciences, Inc(VTYX) | COMM | 92332V107 | $26.8M | 815,724 | 4.4% |
| Dyne Therapeutics, Inc(DYN) | COMM | 26818M108 | $18.6M | 1,650,150 | 3.0% |
| Kura Oncology Inc(KURA) | COMM | 50127T109 | $15.1M | 1,423,642 | 2.5% |
| Structure Therapeutics Inc(GPCR) | ADRS | 86366E106 | $14.5M | 350,000 | 2.4% |
| Immunovant, Inc(IMVT) | COMM | 45258J102 | $12.4M | 654,853 | 2.0% |
| Silence Therapeutics PLC(SLN) | ADRS | 82686Q101 | $11.6M | 2,104,875 | 1.9% |
| An2 Therapeutics, Inc.(ANTX) | COMM | 037326105 | $11.0M | 1,289,320 | 1.8% |
| Entrada Therapeutics Inc(TRDA) | COMM | 29384C108 | $8.9M | 584,955 | 1.5% |
| Merus BV | COMM | N5749R100 | $7.9M | 300,000 | 1.3% |
| Cabaletta BIO, Inc(CABA) | COMM | 12674W109 | $6.3M | 486,795 | 1.0% |
| Aclaris Therapeutics Inc(ACRS) | COMM | 00461U105 | $5.5M | 529,839 | 0.9% |
| C4 Therapeutics, Inc.(CCCC) | COMM | 12529R107 | $3.5M | 1,276,574 | 0.6% |
| Alpine Immune Sciences Inc(NVLSEUR) | COMM | 02083G100 | $2.6M | 253,069 | 0.4% |